Natural History of KCNQ4p.G285S Related Hearing Loss, Construction of iPSC and Mouse Model

Abstract

ObjectiveKCNQ4 is one of the most common disease‐causing genes involved in autosomal dominant non‐syndromic hearing loss. We previously found that patients with KCNQ4 p.G285S exhibited a much more rapid deterioration in hearing loss than those with other KCNQ4 variants. To determine the rate of hearing loss and assess the disease for further analysis, we performed a long‐term follow‐up of these patients and generated patient‐derived induced pluripotent stem cells (iPSCs), and a mouse model.MethodsPatients with KCNQ4 p.G285S from a five‐generation family with hearing loss were followed up from 2005 to 2022. iPSCs were generated by stimulating peripheral blood mononuclear cells from the proband, and their pluripotency was determined. The Kcnq4 p.G286S mouse model was generated using CRISPR/Cas9, and its genotype and phenotype were identified.Results(1) The annual rates of hearing loss at the frequencies of speech were 0.96 dB for the proband and 0.87 dB for his father during the follow‐up period, which were faster than patients with other KCNQ4 variants. (2) The patient‐derived iPSC line carrying KCNQ4 p.G285S, possessed the capacity of differentiation and pluripotency capacities. (3) Mutant mice with Kcnq4 p.G286S exhibited hearing loss and outer hair cell loss at 1 month of age.ConclusionPatients with KCNQ4 p.G285S variant exhibited significantly accelerated progression of hearing loss compared to those with other reported variants. Awareness of the natural history of hearing loss associated with KCNQ4 p.G285S is beneficial for genetic counseling and prognosis. The generation of the iPSCs and mouse model can provide a valuable foundation for further in‐depth analyses.Level of Evidence4 Laryngoscope, 2023